市場調查報告書
商品編碼
1291601
光遺傳學市場:2023-2028年全球行業趨勢、佔有率、規模、成長、機會和預測Optogenetics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028 |
全球光遺傳學市場規模在2022年達到385億美元。展望未來,IMARC Group預計,到2028年,市場規模將達到999億美元,在2023-2028年期間表現出16.41%的成長率(CAGR)。
光遺傳學是指一種科學方法,包括遺傳學和光學技術的結合。它主要用於用光感測器控制和監測神經元和其他類型細胞的生物功能。這些資訊提供了對個體行為和生理學的見解,包括運動、學習、記憶、導航、新陳代謝、呼吸和感測器處理。光遺傳學通過揭示與各種疾病相關的細胞活動,如慢性疼痛、癲癇、帕金森氏症、中風、藥物成癮、強迫症(OCD)、社會功能障礙以及焦慮和抑鬱症,幫助臨床發現。由於這些應用,光遺傳學在神經科學領域被廣泛利用。
由於各種感染、疾病、遺傳性疾病、先天性異常以及大腦、神經和脊髓損傷而促使的神經系統疾病的發病率越來越高,這是目前推動光遺傳學市場發展的關鍵因素之一。與此相呼應,引入纖維耦合發光二極管(LED),將其涵蓋植入物,以實現不受束縛的光傳遞,是另一個主要的成長誘導因素。此外,神經連接、無線微晶片、感測器、細胞表型工具和各種成像工具,如電腦斷層掃描(CT)、位置發射斷層掃描(PET)和磁共振成像(MRI)的快速技術進步,以精確評估器官和組織以識別疾病,正在推動市場成長。由於光遺傳治療方法在細胞、空間和時間上的精確性,醫護人員越來越傾向於光遺傳治療方法,這進一步促進了市場的成長。其他因素,包括醫療支出的增加,神經科學領域廣泛的研究和開發(R&D)活動,以及主要參與者、製藥公司和各國政府之間的戰略合作,以實施有利的政策,支持推出治療神經系統疾病的新藥,正在為市場創造一個積極的前景。
The global optogenetics market size reached US$ 38.5 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 99.9 Billion by 2028, exhibiting a growth rate (CAGR) of 16.41% during 2023-2028.
Optogenetics refers to a scientific approach that includes a combination of genetics and optics technologies. It is primarily used for controlling and monitoring the biological functions of neurons and other types of cells with light sensors. This information provides insights into individual behavior and physiology, including movement, learning, memory, navigation, metabolism, respiration, and sensor processing. Optogenetics aids in clinical discoveries by shedding light on the cellular activities associated with various diseases, such as chronic pain, epilepsy, Parkinson disease, stroke, drug addiction, obsessive compulsion disorder (OCD), social dysfunction, and anxiety and depression. On account of these applications, optogenetics finds extensive utilization in the field of neurosciences.
The increasing prevalence of neurological disorders due to various infections, ailments, genetic disorders, congenital abnormalities, and brain, nerve, and spinal cord injuries is one of the key factors currently driving the optogenetics market growth. In line with this, the introduction of fiber-coupled light-emitting diode (LED) for being incorporated into the implants to enable the untethered light delivery is acting as another major growth-inducing factor. Additionally, rapid technological advancements in neural connectivity, wireless microchip, sensors, cell phenotyping tools, and various imaging tools, like computed tomography (CT), position emission tomography (PET), and magnetic resonance imaging (MRI) to precisely evaluate organs and tissues for identifying disorders is propelling the market growth. The rising inclination of healthcare professionals toward optogenetic therapeutic methodologies on account of its cellular, spatial, and temporal precision is further contributing to the market growth. Other factors, including increasing healthcare expenditure, extensive research and development (R&D) activities in the field of neurosciences, and strategic collaborations between key players, pharmaceutical companies, and governments of various nations to implement favorable policies that support the launch of novel drugs for treating neurological diseases, are creating a positive outlook for the market.
IMARC Group provides an analysis of the key trends in each sub-segment of the global optogenetics market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on light equipment type, application and end user.
Light-emitting Diode (LED)
Laser
Neuroscience
Behavioral Tracking
Retinal Disease Treatment
Others
Hospitals
Clinics
Diagnostic
Research
Others
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The competitive landscape of the industry has also been examined along with the profiles of the key players being Addgene, Coherent Inc., Elliot Scientific Limited, GenSight Biologics S.A., HUBNER GmbH & Co KG, Judges Scientific plc, Laserglow Technologies, Noldus Information Technology, Regenxbio Inc., Shanghai Laser & Optics Century Co. Ltd, The Jackson Laboratory and Thorlabs Inc.
Key Questions Answered in This Report
1. What was the size of the global optogenetics market in 2022?
2. What is the expected growth rate of the global optogenetics market during 2023-2028?
3. What are the key factors driving the global optogenetics market?
4. What has been the impact of COVID-19 on the global optogenetics market?
5. What is the breakup of the global optogenetics market based on the light equipment type?
6. What is the breakup of the global optogenetics market based on the application?
7. What are the key regions in the global optogenetics market?
8. Who are the key players/companies in the global optogenetics market?